Clene (FRA:84C0) Short Interest


FRA:84C0 Clene Inc FRA:84C0
27 GF Score
Price €4.90
GF Value €0.72
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clene Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:84C0 vs BHST, GWLL, FTLF: Short Interest Comparison

For the Packaged Foods subindustry, Clene's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clene Short Interest vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Clene's Short Interest distribution charts can be found below:

* The bar in red indicates where Clene's Short Interest falls into.


FRA:84C0
27GF Score
Clene Inc FRA:84C0
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clene (FRA:84C0) Overvalued in 2026?

Based on GuruFocus' analysis, Clene stock appears to be overvalued. The current stock price of €4.90 is trading 580.6% above its estimated GF Value™ of €0.72. GuruFocus considers Clene to be Significantly Overvalued.

Key valuation signals for FRA:84C0:

  • Short Interest:
  • GF Value™: €0.72 vs. price of €4.90 (580.6% above fair value)
  • GF Score™: 27/100 with 9 warning signs

No single metric tells the full story. See the FRA:84C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clene Business Description

Other Exchanges CLNN:USA
Address 6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
27GF Score

Get the complete analysis for FRA:84C0

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.90
Price
€0.72
GF Value